Article Details

Monoclonal antibody from AstraZeneca lowers risk for serious COVID-19, company says - UPI.com

Retrieved on: 2021-10-11 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Monoclonal antibody from AstraZeneca lowers risk for serious COVID-19, company says - UPI.com. View article details on hiswai:

Excerpt

Monoclonal antibodies are lab-created proteins modeled on those produced by the immune system to fight off infections. AZD7442 is delivered via injection and ...

Article found on: www.upi.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up